Bibliografía - International Union Against Cancer

44. International Agency for Research on Cancer. IARC handbooks on cancer prevention. Vol 8, Fruit and vegetables.
Lyon: IARC Press; 2003.
45. Figueiredo C, Machado JC, Pharoah P et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify
high-risk individuals for gastric carcinoma. J Natl Cancer Inst. 2002;94:1680-7.
46. Covacci A, Telford JL, Del Giudic G et al. Helicobacter pylori virulence and genetic geography. Science. 1999;284:1328-33.
47. Van Doorn LJ, Figueiredo C, Sanna R et al. Clinical relevance of the CagA, vacA, and iceA status of Helicobacter pylori.
Gastroenterology. 1998;115:58-66.
48. Holcombe C. Helicobacter pylori: the African enigma. Gut. 1992;33:429-31.
49. Miwa H, Go MF, Sato N. H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol. 2002;97:1106-12.
50. Haruma K. Trend toward a reduced prevalence of Helicobacter pylori infection, chronic gastritis, and gastric cancer
in Japan. Gastroenterol Clin North Am. 2000;29:623-31.
51. Banatvala N, Mayo K, Megraud F et al. The cohort effect and Helicobacter pylori. J Infect Dis. 1993;168:219-21.
52. Coelho L, Leon-Barua R, Quigley E. Latin-American Consensus Conference on H. pylori infection. Latin-American
Association of Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE).
Am J Gastroenterol. 2000;95(10):2688-91.
53. Lambert R, Guilloux A, Oshima A et al. Incidence and mortality from stomach cancer in Japan, Slovenia and the USA.
Int J Cancer. 2002;97:811-8.
54. Lee A. Prevención de la infección por Helicobacter pylori: posibles candidatos para la vacuna. En: Pajares J, Correa P,
Pérez G (eds). Infección por H. pylori en lesiones gastroduodenales. La segunda década. Barcelona, España: Prous Science;
1998. p.301-14.
55. Rabkin CS, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency
virus type 1. J Natl Cancer Inst. 1994;86:1711-6.
56. Krygier G. Tumores asociados al SIDA. En: Musé I, Viola A, Sabini G (eds.) Aspectos prácticos de la clínica oncológica.
Montevideo: Ed. Sudamericana; 2004. p.527-34.
57. Grulich AE, Li Y, McDonald AM et al. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era
of potent combination anti-retroviral therapy. AIDS. 2001;15:629-33.
58. Jeannel D, Hubert A, de Vathaire F et al. Diet, living conditions and nasopharyngeal carcinoma in Tunisia, a case-control
study. Int J Cancer. 1990;46:421-5.
PREVENCION DEL CANCER: ESTRATEGIAS BASADAS EN LA EVIDENCIA
Una guía de la UICC para América Latina
INFECCIONES
219